Literature DB >> 30589372

Managing immune dysregulation resulting from immune checkpoint inhibitors: impact of the ASCO guidelines and key take-homes for immunologists.

Sang T Kim1, Maria E Suarez-Almazor1.   

Abstract

Keywords:  Cancer immunotherapy; clinical practice guidelines; immune checkpoint inhibitors; immune-related adverse events; toxicity

Mesh：

Substances：

Year:  2018        PMID： 30589372     DOI： 10.1080/1744666X.2019.1559731

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN： 1744-666X            Impact factor:   4.473


× No keyword cloud information.
  2 in total

1.  Immune manifestations with checkpoint inhibitors in a single Brazilian center: experience and literature review.

Authors:  Rafael A Schmerling; Antonio C Buzaid; Carolina K Haddad; Fabio Ab Schutz; Fabio R Kater; Juliana Pimenta; Fernando Maluf; William N William; Camila Lopes; Dafne R Bromberg; Ana C Oliveira; Ricardo Golmia; Morton Scheinberg
Journal:  Future Sci OA       Date:  2020-11-23

2.  [Side effects of novel cancer immunotherapies].

Authors:  G S Braun; M Kirschner; A Rübben; R U Wahl; K Amann; K Benesova; J Leipe
Journal:  Nephrologe       Date:  2020-04-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.